Clinical Trial

Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress

Recruiting
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-30
Trial Details
NCT Number NCT07579845
Lead Sponsor OvationLab
Conditions Detoxification, Inflammation, Biological Aging
Enrollment 60 participants
Start Date 2026-05-05
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-29